Navigation Links
Immune System Protein Could Be the Key Infertility

In a possible breakthrough in the research on male infertility, scientists at the Feinstein Institute for Medical Research in New York say they have found that the level of a substance called macrophage migration inhibitory factor (MIF) in semen could be the key.

The finding, detailed in the latest issue of the journal Molecular Medicine, could lead to fertility tests for males or new types of male contraception, Yousef Al-Abed and his colleagues say.

They first isolated the MIF contained in semen samples collected from 68 infertile and 27 reproductively healthy men.

The samples were collected from men three to five days after a period of sexual abstinence and analyzed by scientists who had no idea which group of men the samples belonged to.

The researchers found that the infertile men had MIF levels that were either too high or too low.

When the scientists added MIF into lab dishes filled with healthy sperm, it decreased the count and impaired their motility.

Those who had no problems conceiving had levels that were just right.

If MIF has a role in infertility, Dr. Al-Abed and his colleagues are wondering whether it might just work as a form of male contraception.

Identified more than 40 years ago, MIF plays an important role in the immune system by promoting inflammation. It is secreted by cells in the male testis and is found in seminal fluid.

Past studies have found it plays a key role in sperm maturation. But MIF has also been linked to several autoimmune and inflammatory diseases, such as diabetes and sepsis, which is a systematic inflammatory response to infection. Unusually high levels of MIF have also been found in individuals suffering from rheumatoid arthritis.

A few years ago UK cancer researchers said they had discovered a molecule that played a key role in the development of sperm.

Sperm cells
'"/>




Page: 1 2

Related medicine news :

1. Immune cells halt round in space
2. Immune function could benefit from exercise
3. Reviving the Immune System
4. Wrestling found To Be Good for the Immune System
5. Immune Boost With LHRH To Help Cancer And Transplant Patients
6. Researchers Find Out The Cause Of Immune Attacks Behind Hearing Loss
7. Block Immune System Chemical For Treating Asthma
8. Immune Response Of Human Beings Can Be Re-energized
9. Weizmann Institute of Science says Immune Cells Could Help Maintain Brain Function
10. Antidepressant drugs interacts with Immune cells
11. Specific Immune Mechanism against DNA viruses

Post Your Comments:
(Date:11/21/2009)...NH based medical credentialing software company In...rm a partnerhsip with Amerinet, Inc., the leading ...ll help to transform quality care within the healt...ovember 21, 2009 -- ISG Group, LLC, doing business...nt with Amerinet Inc., a leading national healthca...
(Date:11/21/2009)...New Haven Dental Group merges their practice with ... , (PRWEB) November 21, 20...tners Dr. David Gibson, Dr. Dean Cloutier, Dr. Joh...ed their growing practice with that of esteemed co...n decided he wanted to retire from dentistry in or...
(Date:11/20/2009)...ov. 20 The American Ac... health care reform legislation released this week...nsurance individual coverage mandate. The actuarie...ill minimize adverse selection stemming from more ...he bill. ,, "The individual mandate language sh...
(Date:11/20/2009)...., Nov. 20 Rates of infe...aked in late October, but the pandemic flu virus c...l age groups, including the elderly, according to ...SE: DGX ), the world,s leading provider of diagn... its most recent Quest Diagnostics Health Trends(T...
(Date:11/20/2009)...N.C., Nov. 20 Samuel Gl...define what it means to be "happy" during the holi...specialty in family counseling and chair of the De...Gladding says research shows that it is the pressu...n depression during the holidays. ,, That,s why...
Breaking Medicine News(10 mins):Health News:IntelliSoft Group and Amerinet Inc. Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 2Health News:New Haven Dental Group Expands Their Vision 2Health News:Actuaries to Senate: Strengthen Individual Mandate 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3Health News:Why Holidays Don't Have To Be 'Happy' 2
...from Company, INDIANAPOLIS, May 28 WellPoint, In...ts Operations, Technology and,Government Services ...ent,and chief executive officer of that organizati...eer, senior vice president of Enterprise,Solutions...
... S&R Communications Group announced,Friday that th... gas card,to one lucky employee each day for the r... A Lot, was created by the S&R upper management in...f," said Paul Dreyer,President. "We offer help to ...
...ome of these procedures may just be matter of conv...ews) -- Premature births of single babies in the U..., and a new report finds that Caesarean sections a.... Alan Fleischman, medical director and senior vic...
...shed in the May 2008 (volume 8, issue 25) edition ...nol (pic-noj-en-all), an antioxidant plant extract...educes blood sugar in type II diabetes patients, ...y of Arizona, Tucson, indicates Pycnogenol may ser...
...ears, Earth observing satellites have delivered va...tter understanding and improved management of the ...are increasing daily as decision-makers are faced ...o address these needs, ESA, the German Space Agenc...
...ponding to the decline in NeoStem,Inc.,s (Amex: N...ading days,Robin Smith, CEO, NeoStem said, "We kno...ould lead to the sudden decline in our share price...ategic investment from the New England Cryogenic C...
Other Medicine News:Health News:WellPoint Announces Realignment of Operations, Technology and Government Services Unit 2Health News:C-Sections Explain Jump in U.S. Preemie Births 2Health News:C-Sections Explain Jump in U.S. Preemie Births 3Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 2Health News:Study shows pine bark naturally reduces cardiovascular risk factors in diabetics 3Health News:European conference addresses increasing demand for EO data 2Health News:NeoStem, Inc. Comments on Recent Selling Pressure 2
(Date:11/20/2009)...Newswire-FirstCall/ -- Cyberonics, Inc. (Nasdaq: ...nd Chief Executive Officer, and Greg Browne, Chief...l Piper Jaffray Health Care Conference in New York...The conference session and webcast will be audio o... Jaffray will host a webcast of the presentation l...
(Date:11/20/2009)...ov. 20 BD (Becton, Dicki...he completion of its acquisition of HandyLab, Inc....ps and manufactures molecular diagnostic assays an...HandyLab announced an exclusive agreement for BD t...e HandyLab Jaguar(TM) platform, the first fully in...
(Date:11/20/2009)... 20 Soligenix, Inc. (OTC... formerly known as DOR BioPharma, Inc., a late-sta...has formed a consortium to develop thermostable te...ting vaccines. Soligenix received a $9.4 million g...fectious Diseases (NIAID), a division of the Natio...
Breaking Medicine Technology:Cyberonics to Present at 21st Annual Piper Jaffray Health Care Conference 2BD Completes Acquisition of HandyLab, Inc. 2BD Completes Acquisition of HandyLab, Inc. 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6Unifi Med 5 0 Complete EMR and Practice Management Solution 5426 1Unifi Med 5 0 Complete EMR and Practice Management Solution 5426 2U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 1U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 2U S Patent Issued for Champions Biotechnologys Lead Oncology Drug 5424 3Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast 5422 1Kendle Announces Details Regarding Third Quarter 2009 Earnings Conference Call and Webcast 5422 2
...y to Submit a Supplemental New Drug Application to...April 6 Cephalon, Inc . (Nasdaq: CEPH ) today ...ical trial of NUVIGIL(R) (armodafinil) Tablets [C-...ated with jet lag disorder. Based on these findin...Application with the U.S. Food and Drug Administra...
...CORE Phase II Testing Certification with Edifecs C...es that are now required in X12 Version 5010 , , ...y that it will, together with its partners CAQH an...s and lessons learned from the CORE Phase II Certi...andated 5010 Rules, in a presentation at the HIMSS...
Other Medicine Technology:Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 2Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 3Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 4Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 2Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 3Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 4Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase 5
... American standard, corrected curve trial lenses a...ed in Marco refractors and are invaluable in treat...ets of other manufacturers contain a disproportion...which are less expensive to produce, and fewer len...
Marco LM-990A
LM-770 Digital Projection Lensemeter
EPIC
Medicine Products: